Citation: Mb. Widmer et al., A soluble TNF receptor-Fc fusion protein (etanercept) in the treatment of inflammatory diseases, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 251-263
Authors:
Borish, LC
Nelson, HS
Lanz, MJ
Claussen, L
Whitmore, JB
Agosti, JM
Garrison, L
Citation: Lc. Borish et al., Interleukin-4 receptor in moderate atopic asthma - A phase I/II randomized, placebo-controlled trial, AM J R CRIT, 160(6), 1999, pp. 1816-1823
Authors:
Jones, SE
Khandelwal, P
McIntyre, K
Mennel, R
Orr, D
Kirby, R
Agura, E
Duncan, L
Hyman, W
Roque, T
Regan, D
Schuster, M
Dimitrov, N
Garrison, L
Lange, M
Citation: Se. Jones et al., Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin,and cyclophosphamide in stage II and III breast cancer, J CL ONCOL, 17(10), 1999, pp. 3025-3032
Authors:
Moreland, LW
Schiff, MH
Baumgartner, SW
Tindall, EA
Fleischmann, RM
Bulpitt, KJ
Weaver, AL
Keystone, EC
Furst, DE
Mease, PJ
Ruderman, EM
Horwitz, DA
Arkfeld, DG
Garrison, L
Burge, DJ
Blosch, CM
Lange, MLM
McDonnell, ND
Weinblatt, ME
Citation: Lw. Moreland et al., Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial, ANN INT MED, 130(6), 1999, pp. 478